AMGN
Amgen Inc
379.80$
+0.9%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 53.5% | 31.2% | 30.1% | 29.9% | 29.5% | 31.6% | 30.1% | 30.4% | 30.9% | 32.1% | 34.0% | 36.6% | |
| 38.4% | 11.3% | 10.4% | 10.2% | 9.9% | 13.0% | 9.9% | 9.1% | 10.5% | 10.1% | 13.0% | 14.6% | |
| 38.4% | 11.3% | 10.4% | 10.2% | 9.9% | 13.0% | 9.9% | 9.1% | 10.5% | 10.1% | 13.0% | 14.6% | |
| 6.8% | 8.2% | 7.3% | 7.6% | 8.1% | 8.2% | 9.1% | 9.9% | 9.4% | 10.6% | 9.9% | 10.7% | |
| 5.6% | 9.8% | 9.4% | 8.8% | 8.1% | 7.6% | 7.5% | 7.5% | 7.0% | 6.9% | 6.7% | 6.5% | |
| 17.1% | 19.2% | 20.0% | 20.5% | 20.5% | 20.3% | 20.9% | 21.2% | 20.7% | 20.6% | 20.2% | 19.5% | |
| 14.5% | 33.6% | 33.7% | 33.2% | 31.8% | 30.2% | 28.8% | 28.0% | 25.7% | 24.6% | 23.1% | 21.4% | |
| 91.5% | 93.6% | 94.6% | 93.5% | 91.7% | 93.6% | 93.1% | 91.5% | 89.3% | 90.4% | 90.1% | 87.8% | |
| 18.7% | 18.9% | 21.2% | 23.7% | 22.3% | 25.2% | 25.7% | 23.3% | 24.2% | 28.1% | 27.0% | 26.7% | |
| 1.6% | 1.5% | 4.3% | 6.1% | 3.9% | 3.9% | 3.8% | 2.8% | 2.4% | 5.1% | 5.9% | 5.7% | |
| 1.5% | 1.6% | 1.8% | 2.5% | 2.4% | 2.1% | 2.7% | 3.4% | 3.1% | 2.6% | 3.2% | 21.0% | |
| 65.2% | 65.0% | 64.6% | 62.8% | 62.6% | 61.6% | 60.4% | 61.2% | 58.2% | 55.2% | 56.1% | 54.2% | |
| 8.5% | 6.4% | 5.4% | 6.5% | 8.3% | 6.4% | 6.9% | 8.5% | 10.7% | 9.6% | 9.9% | 12.2% | |
| -27.6% | -27.3% | -30.0% | -29.8% | -28.1% | -30.0% | -30.4% | -29.2% | -26.4% | -27.7% | -26.6% | -23.3% | |
| 0.6% | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.